e-Spirit News

BAYRY has been the subject of a number of other recent research reports. Analysts at Societe Generale initiated coverage on shares of Bayer AG in a research note to investors on Thursday, May 10th.

FRANKFURT German pharmaceutical company Bayer AG Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Administration advisory panel voted against expanded use of the blood thinner.The FDA advisers narrowly voted against the use of the anti-clotting pill to treat patients with a heart problem ... (more)

The Redwood City-based cancer drug developer, one of the most successful Bay Area biotech companies at raising venture capital over the past five years, said it will use proceeds of the IPO to advance its lead drug -- demcizumab, or OMP-21M18 -- and two other drugs into Phase II clinical trials and for programs with partners GlaxoSmithKline and ... (more)

The firm set a "hold" rating on the stock. A number of other analysts have also recently weighed in on BAYRY.

Initially the bilingual corporate website is to be rebuilt with the system, followed by the national websites.

Spirit, a national business plan competition for Aboriginal youth, will see 160 Grade 10 to 12 students vie for awards at the University of Manitoba in Winnipeg, May 15 to 17.

Dortmund, May 02, 2012 - e-Spirit, manufacturer of the FirstSpirit Content Management System , has founded a new subsidiary in Switzerland.

's stock had its "neutral" rating reiterated by Zacks in a research note issued to investors on Tuesday.